$1.94
1.31% today
Nasdaq, Sep 19, 05:41 pm CET
ISIN
US0043971052
Symbol
ARAY

Accuray Incorporated Stock price

$1.91
-0.44 18.72% 1M
-0.66 25.68% 6M
-0.92 32.51% YTD
-0.80 29.52% 1Y
-1.60 45.58% 3Y
-1.01 34.59% 5Y
-6.19 76.42% 10Y
Nasdaq, Closing price Wed, Sep 18 2024
+0.01 0.53%
ISIN
US0043971052
Symbol
ARAY
Sector

Key metrics

Market capitalization $189.56m
Enterprise Value $331.25m
P/E (TTM) P/E ratio negative
EV/Sales (TTM) EV/Sales 0.74
P/S ratio (TTM) P/S ratio 0.42
P/B ratio (TTM) P/B ratio 4.61
Revenue growth (TTM) Revenue growth -0.24%
Revenue (TTM) Revenue $446.55m
EBIT (operating result TTM) EBIT $504.00k
Cash position $69.06m
EPS (TTM) EPS $-0.16
P/E forward negative
P/S forward 0.41
EV/Sales forward 0.72
Short interest 4.29%
Show more

Is Accuray Incorporated a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.

Accuray Incorporated Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Accuray Incorporated forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Accuray Incorporated forecast:

Buy
100%

Financial data from Accuray Incorporated

Jun '24
+/-
%
Net Profit 3.39 3.39
232% 232%
3%
Depreciation and Amortization 1.51 1.51
37% 37%
1%
Stock Compensation - -
-
-
Operating Cash Flow - -
-
-
Investments - -
-
-
Dividend Paid - -
-
-
Free Cash Flow - -
-
-

In millions USD.

Don't miss a Thing! We will send you all news about Accuray Incorporated directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Accuray Incorporated Stock News

Neutral
PRNewsWire
9 days ago
The Technology Will Play an Important Role in the Hospital's Plan to Expand Patient Access to High Precision Radiation Therapy Treatments MADISON, Wis. , Sept. 10, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Gifu Prefectural General Medical Center is setting a new standard in cancer care in Japan as the first hospital in the country to treat patients with surfa...
Neutral
PRNewsWire
16 days ago
MADISON, Wis. , Sept. 3, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that President and Chief Executive Officer Suzanne Winter will be taking a temporary medical leave of absence to receive care for a treatable form of cancer, effective immediately.
Neutral
PRNewsWire
23 days ago
Developed for India and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority Drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems MADISON, Wis. , Aug. 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has rece...
More Accuray Incorporated News

Company Profile

Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

Head office United States
CEO Sandeep Chalke
Founded 1990
Website www.accuray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today